Valuation Castle Biosciences, Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-10-01 EDT			5-day change	1st Jan Change
35.26 ^USD	-0.77%		+0.18%	-9.37%

09-24	Castle Biosciences, Inc. Announces Publication of New Study Highlighting Clinical Need for Molecular Guidance in Atopic Dermatitis Treatment Selection, Reinforcing the Value of Advancead-Tx	CI
09-22	Castle Biosciences to Open New Lab in Arizona	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	1,103	620.3	580.7	746.4	1,135	1,077	-	-
Change	-	-43.76%	-6.38%	28.53%	52.12%	-5.14%	-	-
Enterprise Value (EV)	773.4	361.7	337.6	746.4	1,135	1,077	1,077	1,077
Change	-	-53.23%	-6.65%	121.07%	52.12%	-5.14%	0%	0%
P/E	-34.6x	-9.12x	-10.1x	43x	-46.9x	-27.8x	-37.5x	-89.3x
PBR	2.62x	1.54x	1.48x	1.71x	2.39x	2.27x	2.19x	-
PEG	-	-0x	0.6x	-0x	0x	-0.5x	1.4x	1.5x
Capitalization / Revenue	11.7x	4.53x	2.64x	2.25x	3.3x	2.89x	2.62x	2.34x
EV / Revenue	0x	0x	0x	0x	0x	2.89x	2.62x	2.34x
EV / EBITDA	-0x	-0x	-0x	0x	0x	98.6x	45.9x	26.6x
EV / EBIT	-0x	-0x	-0x	0x	-0x	-23.1x	-32.4x	-64.9x
EV / FCF	-0x	-0x	-0x	0x	0x	-50.1x	80.7x	37x
FCF Yield	-2.04%	-7.62%	-3.31%	4.9%	2.49%	-2%	1.24%	2.7%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-1.24	-2.58	-2.14	0.62	-0.83	-1.267	-0.9389	-0.395
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	94.08	137	219.8	332.1	344.2	373.2	411.6	460.1
EBITDA ¹	-36.67	-62.31	-55.65	74.99	43.85	10.92	23.47	40.49
EBIT ¹	-40.08	-72.86	-67.98	8.67	-42.81	-46.6	-33.25	-16.59
Net income ¹	-31.29	-67.14	-57.47	18.24	-24.16	-37.78	-25.64	-9.418
Net Debt	-329.6	-258.6	-243.1	-	-	-	-	-
Reference price ²	42.87	23.54	21.58	26.65	38.90	35.26	35.26	35.26
Nbr of stocks (in thousands)	25,730	26,352	26,911	28,007	29,189	30,550	-	-
Announcement Date	2/28/22	2/28/23	2/28/24	2/27/25	2/26/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CASTLE BIOSCIENCES, INC.	-27.83x	-	-	-	1.08B
ABBOTT LABORATORIES	27.39x	3.81x	14.72x	2.66%	167B
MEDTRONIC PLC	18.26x	3.37x	12.05x	3.26%	111B
STRYKER CORPORATION	21.23x	4.18x	14.6x	1.32%	105B
ESSILORLUXOTTICA	25.57x	2.51x	10.15x	2.82%	74.82B
CENCORA, INC.	16.96x	0.2x	12.44x	0.77%	59.11B
HOYA CORPORATION	29.74x	7.35x	19.01x	1.35%	51.8B
BECTON, DICKINSON AND COMPANY	34.32x	3.34x	11.44x	2.2%	48.5B
IDEXX LABORATORIES, INC.	35.06x	8.71x	24.52x	-.--%	40.79B
DEXCOM, INC.	34.65x	6.08x	19.07x	-.--%	32.54B
Average	21.54x	4.39x	15.33x	1.6%	69.12B
Weighted average by Cap.	25.28x	3.97x	14.46x	1.99%